Article · 29 Dec 2025
Conference abstractPublished 27 Oct 2014
The positive role of intellectual property in the creation of cost effective and affordable biosimilars
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Intellectual property particularly patents are considered to be road blocks in the development and prolific use of Biosimilars. The drug and pharmaceuticals business tends to equate Biosimilars with synthetic generics. However this comparison is unwarranted since cell lines developed independently can never be identical. Biosimilars can never be copied. They can only be developed independently. Also it takes infinitely more effort and expense to develop Biosimilars. Patents are territorial in nature. Each country has its own rules for covering active drug substances made by or derived from a living organism for example by use of recombinant DNA or uncontrolled gene expression. Also biologic medical products covered in one country may not be covered in others. Therefore there is a vast storehouse of technology reported in patent documents in one country that is waiting to be worked in another country where a patent application was not filed. Biosimilars researches and manufactures should make it a point to use the database of patents available to them as the basic research source to build new cell lines and create their own molecular clones and cell banks. These documents provide details of new fermentation and purification processes to create Biosimilars with reduced side effects and less threatening immunogenic responses. Patent documents also provide new techniques for assays and pharmocovigilance plans.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Mohan Dewan”
